|4Mar 6, 5:10 PM ET

VERACYTE, INC. 4

4 · VERACYTE, INC. · Filed Mar 6, 2017

Insider Transaction Report

Form 4
Period: 2017-03-03
Brooks Julie
EVP,General Counsel,Secretary
Transactions
  • Award

    Common Stock

    2017-01-31$4.23/sh+377$1,5954,162 total
  • Award

    Stock Option (right to buy)

    2017-03-03+60,00060,000 total
    Exercise: $9.05Exp: 2027-03-03Common Stock (60,000 underlying)
Footnotes (2)
  • [F1]Purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
  • [F2]The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

Documents

1 file
  • 4
    wf-form4_148883822860329.xmlPrimary

    FORM 4